Shield Therapeutics PLC
F:1JS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Shield Therapeutics PLC
F:1JS
|
UK |
|
IP Group PLC
F:IOOA
|
UK |
|
A
|
Agios Pharmaceuticals Inc
F:8AP
|
US |
|
A
|
ASMPT Ltd
F:AY7A
|
SG |
|
Fraport AG Frankfurt Airport Services Worldwide
F:FRA
|
DE |
|
G
|
Gold Fields Ltd
XMUN:EDGA
|
ZA |
|
P
|
Proodeftiki Technical Co SA
ATHEX:PRD
|
GR |
|
GSP Resource Corp
F:0YD
|
CA |
|
Biomind Labs Inc
OTC:BMNDF
|
CA |
|
EO2 SA
F:EO4
|
FR |
|
Optima Bank SA
F:C59
|
GR |
|
C
|
Citigold Corporation Ltd
SWB:CHP
|
AU |
|
A
|
Aikchol Hospital PCL
SET:AHC
|
TH |
Bankruptcy Probability
Shield Therapeutics PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Shield Therapeutics PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
|
Shield Therapeutics PLC
LSE:STX
|
63.7m GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
622.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
355B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
338.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
224.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
184.1B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
317B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
160.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Shield Therapeutics PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Shield Therapeutics PLC has total debt of 24.9m USD. This includes both short-term (0 USD) and long-term (24.9m USD) debt.
You can find a full breakdown on its Balance Sheet.